Cell therapy spinout targets liver repair treatment
From Eleanor Roger on December 2nd, 2020
Advanced liver damage could be treated and repaired instead of requiring a transplant thanks to a University of Edinburgh spinout company. Resolution Therapeutics Ltd is based on a decade of research from the Forbes lab at the Centre for Regenerative Medicine.
It has received funding of £26.6 million from Syncona Ltd, a specialist healthcare investment company. The investment is expected to enable Resolution to gain early clinical data for its first product.